Appropriates $400,000 in recurring funds and $9,180,066 in nonrecurring funds for 2021-22  from the General Fund to the Department of Health and Human Services, Division of Mental Health, Developmental Disabilities, and Substance Abuse Services (DMH/DD/SAS), to be allocated in the specified amounts to the six named nonprofit corporations that provide opioid use disorder treatment. Requires fund recipients to report expenditures by April 1, 2022, to the DMH/DD/SAS. Requires DMH/DD/SAS to report this information by May 1, 2022, to the specified NCGA committee and division. Effective July 1, 2021.